Search results
Results from the WOW.Com Content Network
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
Despite operating for nearly two decades without profit, 23andMe went public in 2021 and reached a $6 billion valuation. The company's stocks were priced at $11.13 a share, but they've fallen ...
The downfall of 23andMe highlights the hidden costs of its earlier success. The recent $30 million settlement over 23andMe’s data breach underscores the industry’s failure to safeguard ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
The 23andMe data leak was a data breach at personal genomics company 23andMe reported in October 2023. The cyberattack gathered profile and ethnicity information from millions of users. The affected customers were reported as primarily Ashkenazi Jews but also including hundreds of thousands of ethnically Chinese users. [ 1 ]
23andMe faces uncertainty amid acquisition talks and board resignations, and users are worried about their data. Here's what the company says.
Meanwhile, 23andMe’s drug research (a notoriously expensive and often fruitless business) has also failed to generate significant revenue. The company is now worth less than $200 million — a ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.